| MACHOVÁ POLÁKOVÁ, Kateřina, Sylvie NÁDVORNÍKOVÁ, Karla ZEMANOVÁ, Hana KLAMOVÁ, Tomáš JURČEK, Dana DVOŘÁKOVÁ, Daniela ŽÁČKOVÁ, Jiří MAYER, Marek TRNĚNÝ a Jana MORAVCOVÁ. Minimal residual resistance in CML: Stable BCR-ABL gene expression at levels 0.01-0.1% (IS) in the consecutive samples may be associated with BCR-ABL mutation development and MMoR lost in a small number of tyrosine kinase inhibitor responders. In 52nd annual meeting ASH in Blood. 2010. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{917157,
author = {Machová Poláková, Kateřina and Nádvorníková, Sylvie and Zemanová, Karla and Klamová, Hana and Jurček, Tomáš and Dvořáková, Dana and Žáčková, Daniela and Mayer, Jiří and Trněný, Marek and Moravcová, Jana},
booktitle = {52nd annual meeting ASH in Blood},
language = {eng},
title = {Minimal residual resistance in CML: Stable BCR-ABL gene expression at levels 0.01-0.1% (IS) in the consecutive samples may be associated with BCR-ABL mutation development and MMoR lost in a small number of tyrosine kinase inhibitor responders.},
year = {2010}
}
TY - CONF
ID - 917157
AU - Machová Poláková, Kateřina - Nádvorníková, Sylvie - Zemanová, Karla - Klamová, Hana - Jurček, Tomáš - Dvořáková, Dana - Žáčková, Daniela - Mayer, Jiří - Trněný, Marek - Moravcová, Jana
PY - 2010
TI - Minimal residual resistance in CML: Stable BCR-ABL gene expression at levels 0.01-0.1% (IS) in the consecutive samples may be associated with BCR-ABL mutation development and MMoR lost in a small number of tyrosine kinase inhibitor responders.
ER -
MACHOVÁ POLÁKOVÁ, Kateřina, Sylvie NÁDVORNÍKOVÁ, Karla ZEMANOVÁ, Hana KLAMOVÁ, Tomáš JURČEK, Dana DVOŘÁKOVÁ, Daniela ŽÁČKOVÁ, Jiří MAYER, Marek TRNĚNÝ a Jana MORAVCOVÁ. Minimal residual resistance in CML: Stable BCR-ABL gene expression at levels 0.01-0.1\%{} (IS) in the consecutive samples may be associated with BCR-ABL mutation development and MMoR lost in a small number of tyrosine kinase inhibitor responders. In \textit{52nd annual meeting ASH in Blood}. 2010.
|
